Solace Pharmaceuticals UK Ltd.
Records under this name other than patents Solace Pharmaceuticals UK Ltd. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 4 of 4 · Back to Solace Pharmaceuticals UK Ltd.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 10,059,664 | Sepiapterin Reductase Inhibitors for the Treatment of Pain Formerly held Lapsed on the fee record Ended Aug 28, 2022 · Medium confidence | Lapsed on the fee record | Ended Aug 28, 2022 | Medium confidence |
| US 9,169,234 | Sepiapterin reductase inhibitors for the treatment of pain Lapsed on the fee record Ended Oct 27, 2019 · From the USPTO record | Lapsed on the fee record | Ended Oct 27, 2019 | From the USPTO record |
| US 5,409,935 | Xanthine derivatives for the treatment of secondary nerve cell damage and functional disorders after cranio-cerebral traumas Term ended Term ended no later than Apr 25, 2015 · Low confidence | Term ended | Term ended no later than Apr 25, 2015 | Low confidence |
| US 5,475,002 | Use of 1-(5-oxohexyl)-3-methyl-7-n-propylxanthine in vascular surgery Term ended Term ended no later than Dec 12, 2015 · Low confidence | Term ended | Term ended no later than Dec 12, 2015 | Low confidence |